Skip to main content

In this time of the COVID19 pandemic, Open Therapeutics is positioned to support the scientific community with its free collaborative platform, Therapoid, serological lab kits, and personal protective equipment (PPE).

Open Therapeutics facilitates therapeutic (pharma, medical devices, and diagnostics) developments by enabling capable and responsible researchers around the world to collaborate. Open Therapeutics has two components: (i) an open web platform for scientific collaboration known as Therapoid, and (ii) open technologies and intellectual properties (IP) for rapid prototyping of therapeutics.

Open Therapeutics enables an  and collaboration community. The goal is to lower costs, reduce risks, shorten timelines, and broaden markets for therapeutics.  Open Therapeutics is proud to have provided the “Open Science” icon free for the world to use under a “Creative Commons Attribution-ShareAlike 4.0 (CC-BY-SA-4.0) or (CC4.0) license.  This is inline with the Company’s philosophy of providing free tools, services, and intellectual properties (IP) to researchers for free under an CC4.0 license.  More about Creative Commons license: Creative Commons License Creative Commons Attribution-ShareAlike 4.0 International License.

The Therapoid web portal enables international scientists to share research easily, while it also opens a path to develop dormant technologies. Simple to use tools enable more effective collaboration. The combination of collaboration and biotechnologies will lead to better therapeutics for patients in every country.

The Open Therapeutics Therapoid platform is freely available.  In the near future, we anticipate enabling researchers to earn a cryptocurrency.

Therapoid™ integrates open biotechnologies, funding, manuscript development prePeer Review, prePrint Server, open access, open data, artificial intelligence, and blockchain into a unified crowdsourcing ecosystem.

Therapoid enables adopters, innovators, and observers at non-profit and for-profit institutions to collaborate on biotechnologies normally closed off to researchers. We deploy open biotechnologies and distribute our therapeutic development platforms under open licenses.

By registering to use the Therapoid platform, you explicitly agree to accept a Creative Commons-like user agreement. Once you become a collaborator, we will ask you to agree explicitly to use open licenses for the development of any relevant technologies and knowledge.

Therapoid is currently released as an “alpha” test version. During this phase, we invite only select users, researchers, and innovators to help develop the core framework. We expect to launch the beta version to a wider user group in the third quarter of 2017.

If you are interested in becoming a beta user, please contact us.

Please see our Open Therapeutics’ company brochure.

Please read our Open Therapeutics’ Open Therapeutics white paper.

Read more about the philosophy of Open Therapeutics in the following PDF: Our Philosophy

Our Story
“Science and Collaboration should have no borders.”

Founded in 2009, Open Therapeutics is a global life sciences biotech company. Our wide array of bio-technologies will be available on the industry’s first crowd-sourcing web platform at Therapoid.

Therapoid focuses on eliminating obstacles to global research and collaboration by encouraging scientific peer-to-peer communication, stimulating synergies in scientific R&D, and significantly driving down research costs – ultimately making healthcare accessible and affordable to the global community. Through our crowd-sourcing web platform, we gather and enhance research, clinical and interactive data, developing a wide-array of assets and useful information then made available to the scientific community.

Our Vision
To empower, enable and accelerate global therapeutic solutions.

Our Mission
Our passion is making healthcare available to all human beings regardless of geography. We believe strongly that scientific collaboration free of constraints is paramount to promoting diversity in research and reducing the cost of healthcare.

  • To create a neutral and transparent platform for the free flow of scientific research
  • To be the platform of choice among the scientific and medical community
  • To be the driving agent in scientific collaboration
  • To make healthcare accessible and affordable by creating an open ecosystem for research

Our Values
At Open Therapeutics, we pride ourselves on a core set of values that is aligned with our mission.  These principles are the foundation that drives our every day activities.

  • We believe strongly in treating all members of our community with mutual trust and respect.
  • We believe that proliferation of technologies can occur through open and transparent interactions.
  • We believe that our mission can be supported through collaboration within the scientific community.
  • We focus our entire effort on making an impact in the world of scientific research.
  • We believe passionately in a research world free of silos.

Our Team



Our Effort

Open Therapeutics is a major backer of open science and open access efforts.

Open Therapeutics freely provides to science, technology, engineering, and math (STEM) scientists, or another other seriously interested persons, intellectual properties (patents, etc.), grant funding, lab equipment, document development tools, and preprint server in a collaboration platform (Therapoid™).

When the researchers advance the intellectual properties, s/he gains ScienceCoins™; a blockchain-based cryptocurrency.

Please read our Open Therapeutics’ company whitepaper.